Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes

od Gibbons, Catherine, Blundell, John, Tetens Hoff, Søren, Dahl, Kirsten, Bauer, Robert, Bækdal, Tine
Izdano u Diabetes Obes Metab (2020)

Ex vivo mRNA expression of toll-like receptors during latent tuberculosis infection

od Alemnew, Birhan, Hoff, Soren T., Abebe, Tamrat, Abebe, Markos, Aseffa, Abraham, Howe, Rawleigh, Wassie, Liya
Izdano u BMC Immunol (2021)

Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes

od Dahl, Kirsten, Brooks, Ashley, Almazedi, Firas, Hoff, Søren Tetens, Boschini, Cristina, Bækdal, Tine A.
Izdano u Diabetes Obes Metab (2021)

Randomised Clinical Trial Investigating the Specificity of a Novel Skin Test (C-Tb) for Diagnosis of M. tuberculosis Infection

od Aggerbeck, Henrik, Giemza, Rafaela, Joshi, Paulatsya, Tingskov, Pernille N., Hoff, Søren T., Boyle, Julia, Andersen, Peter, Lewis, David J. M.
Izdano 2013

First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent

od Bergstedt, Winnie, Tingskov, Pernille N., Thierry-Carstensen, Birgit, Hoff, Søren T., Aggerbeck, Henrik, Thomsen, Vibeke O., Andersen, Peter, Andersen, Aase B.
Izdano 2010

Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls

od Zewdie, Martha, Howe, Rawleigh, Hoff, Søren T., Doherty, T. Mark, Getachew, Nahom, Tarekegne, Azeb, Tessema, Bamlak, Yamuah, Lawrence, Aseffa, Abraham, Abebe, Markos
Izdano u Tuberculosis (Edinb) (2016)

The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders

od Michelsen, Sascha Wilk, Soborg, Bolette, Diaz, Lars Jorge, Hoff, Soren Tetens, Agger, Else Marie, Koch, Anders, Rosenkrands, Ida, Wohlfahrt, Jan, Melbye, Mads
Izdano u PLoS One (2017)

Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

od Zinman, Bernard, Aroda, Vanita R., Buse, John B., Cariou, Bertrand, Harris, Stewart B., Hoff, Søren Tetens, Pedersen, Karen Boje, Tarp-Johansen, Mads Jeppe, Araki, Eiichi
Izdano u Diabetes Care (2019)

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial

od Aggerbeck, Henrik, Ruhwald, Morten, Hoff, Søren T., Borregaard, Bettine, Hellstrom, Elizabeth, Malahleha, Mookho, Siebert, Mirna, Gani, Mashra, Seopela, Vincent, Diacon, Andreas, Lourens, Madeleine, Andersen, Peter, Dheda, Keertan
Izdano u PLoS One (2018)

Development of a One-Step Probe Based Molecular Assay for Rapid Immunodiagnosis of Infection with M. tuberculosis Using Dried Blood Spots

od Blauenfeldt, Thomas, Heyckendorf, Jan, Graff Jensen, Sidse, Lange, Christoph, Drabe, Camilla, Hermansen, Thomas S., de Thurah, Lena, Lillebaek, Troels, Eugen-Olsen, Jesper, Seersholm, Niels, Hoff, Søren, Bonde, Jesper, Ruhwald, Morten
Izdano 2014

Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4(+) T Cells

od Lenz, Nicole, Schindler, Tobias, Kagina, Benjamin M., Zhang, Jitao David, Lukindo, Tedson, Mpina, Maxmillian, Bang, Peter, Kromann, Ingrid, Hoff, Søren T., Andersen, Peter, Reither, Klaus, Churchyard, Gavin J., Certa, Ulrich, Daubenberger, Claudia A.
Izdano u Clin Vaccine Immunol (2015)

A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area

od Hussein, Jemal, Zewdie, Martha, Yamuah, Lawrence, Bedru, Ahmed, Abebe, Markos, Dagnew, Alemnew F., Chanyalew, Menberework, Yohannes, Asfawesen G., Ahmed, Jemal, Engers, Howard, Doherty, T. Mark, Bang, Peter, Kromann, Ingrid, Hoff, Søren T., Aseffa, Abraham
Izdano u Trials (2018)

Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6

od Ruhwald, Morten, de Thurah, Lena, Kuchaka, Davis, Zaher, Mostafa Rafaat, Salman, Ahmed M., Abdel-Ghaffar, Abdel-Rahman, Shoukry, Faten Aly, Michelsen, Sascha Wilk, Soborg, Bolette, Blauenfeldt, Thomas, Mpagama, Stellah, Hoff, Søren T., Agger, Else Marie, Rosenkrands, Ida, Aagard, Claus, Kibiki, Gibson, El-Sheikh, Nabila, Andersen, Peter
Izdano u Sci Rep (2017)

Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm(3): A Phase II, Multi-Centre,...

od Reither, Klaus, Katsoulis, Lynn, Beattie, Trevor, Gardiner, Nicolene, Lenz, Nicole, Said, Khadija, Mfinanga, Elirehema, Pohl, Christian, Fielding, Katherine L., Jeffery, Hannah, Kagina, Benjamin M., Hughes, Elisabeth J., Scriba, Thomas J., Hanekom, Willem A., Hoff, Søren T., Bang, Peter, Kromann, Ingrid, Daubenberger, Claudia, Andersen, Peter, Churchyard, Gavin J.
Izdano u PLoS One (2014)

Antigen availability shapes T cell differentiation and function during tuberculosis

od Moguche, Albanus O., Musvosvi, Munyaradzi, Penn-Nicholson, Adam, Plumlee, Courtney R., Mearns, Helen, Geldenhuys, Hennie, Smit, Erica, Abrahams, Deborah, Rozot, Virginie, Dintwe, One, Hoff, Søren T., Kromann, Ingrid, Ruhwald, Morten, Bang, Peter, Larson, Ryan P., Shafiani, Shahin, Ma, Shuyi, Sherman, David R., Sette, Alessandro, Lindestam Arlehamn, Cecilia S., McKinney, Denise M., Maecker, Holden, Hanekom, Willem A., Hatherill, Mark, Andersen, Peter, Scriba, Thomas J., Urdahl, Kevin B.
Izdano u Cell Host Microbe (2017)